1. Home
  2. AVT vs IMVT Comparison

AVT vs IMVT Comparison

Compare AVT & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avnet Inc.

AVT

Avnet Inc.

N/A

Current Price

$92.38

Market Cap

8.0B

Sector

Technology

ML Signal

N/A

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$29.47

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVT
IMVT
Founded
1921
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AVT
IMVT
Price
$92.38
$29.47
Analyst Decision
Hold
Buy
Analyst Count
4
17
Target Price
★ $106.25
$48.88
AVG Volume (30 Days)
1.1M
★ 1.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
★ 1.58%
N/A
EPS Growth
★ 45.82
N/A
EPS
★ 4.01
N/A
Revenue
★ $27,632,683,000.00
N/A
Revenue This Year
$34.12
N/A
Revenue Next Year
$5.84
N/A
P/E Ratio
$23.27
★ N/A
Revenue Growth
★ 24.47
N/A
52 Week Low
$44.25
$21.43
52 Week High
$108.63
$45.42

Technical Indicators

Market Signals
Indicator
AVT
IMVT
Relative Strength Index (RSI) 45.61 40.63
Support Level $83.82 $25.83
Resistance Level $95.26 $29.83
Average True Range (ATR) 2.99 1.11
MACD -0.40 0.42
Stochastic Oscillator 46.26 73.73

Price Performance

Historical Comparison
AVT
IMVT

About AVT Avnet Inc.

Avnet Inc is an electronic component technology distributor and solutions provider serving customers across the Americas, EMEA, and Asia. It works with electronic component manufacturers in every electronic component segment and serves startups, mid-sized businesses, enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). Its segments are Electronic Components (EC) and Farnell, with EC generating maximum revenue. The EC operating group mainly supports high- and medium-volume customers and markets, and sells and distributes semiconductors, IP&E components (interconnect, passive, and electromechanical components), and other integrated and embedded components.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: